z-logo
Premium
Acetaminophen glucuronide and plasma glucose report identical estimates of gluconeogenesis and glycogenolysis for healthy and prediabetic subjects using the deuterated water method
Author(s) -
Barosa Cristina,
Jones John G.,
Rizza Robert,
Basu Ananda,
Basu Rita
Publication year - 2013
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.24485
Subject(s) - medicine , endocrinology , gluconeogenesis , glycogenolysis , chemistry , glucuronide , impaired glucose tolerance , carbohydrate metabolism , metabolism , urinary system , diabetes mellitus , insulin resistance
Plasma glucose 2 H‐enrichment in positions 5 ( 2 H5) and 2 ( 2 H2) from deuterated water ( 2 H 2 O) provides a measure of the gluconeogenic contribution to endogenous glucose production. Urinary glucuronide analysis can circumvent blood sampling but it is not known if glucuronide and glucose enrichments are equal. Thirteen subjects with impaired fasting glucose/impaired glucose tolerance and 11 subjects with normal fasting glucose and normal glucose tolerance ingested 2 H 2 O to ∼0.5% body water and acetaminophen. Glucose and glucuronide 2 H5 and 2 H2 were measured by 2 H NMR spectroscopy of monoacetone glucose. For normal fasting glucose/normal glucose tolerance, 2 H5 was 0.23 ± 0.02% and 0.25 ± 0.02% for glucose and glucuronide, respectively, whereas 2 H2 was 0.47 ± 0.01% and 0.49 ± 0.02%, respectively. For impaired fasting glucose/impaired glucose tolerance, 2 H5 was 0.22 ± 0.01% and 0.26 ± 0.02% for glucose and glucuronide, respectively, whereas 2 H2 was 0.46 ± 0.01% and 0.49 ± 0.02%, respectively. The gluconeogenic contribution to endogenous glucose production measured from glucose and glucuronide were identical for both normal fasting glucose/normal glucose tolerance (48 ± 4 vs. 51 ± 3%) and impaired fasting glucose/impaired glucose tolerance (48 ± 2 vs. 53 ± 3%). Magn Reson Med 70:315–319, 2013. © 2012 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here